Bifidobacterium longum immune-enhancing composition for increasing igA level
By scientifically combining active probiotics and heat-inactivated biogenerants, along with compound excipients and advanced preparation processes, the problems of easy inactivation and insufficient stability of existing products in the acidic environment of the stomach have been solved, achieving highly efficient immune enhancement effects and wide application.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- UWORTH (HAINAN) TECHNOLOGY CONSULTING CO LTD
- Filing Date
- 2026-05-15
- Publication Date
- 2026-07-17
AI Technical Summary
Existing probiotic products for enhancing immunity lack scientifically formulated strains and postbiotic pairings, resulting in poor immune regulation effects. Probiotics are easily inactivated in the acidic environment of the stomach, leading to insufficient product stability and palatability. Traditional preparation processes lack standardization, affecting practical application effects.
By employing a scientific ratio of active probiotics and heat-inactivated probiotics, and through the combination of compound excipients and a double-layer encapsulation structure, along with anaerobic and aerobic fermentation, low-temperature centrifugation, precise heat inactivation, and vacuum freeze-drying processes, a Bifidobacterium immune-enhancing composition that improves IgA levels was prepared.
It achieves the synergistic effect of probiotics and postbiotics, enhances the body's mucosal immune IgA level, and ensures the stability and palatability of the composition in the gastric acid environment, making it suitable for the food and health food industries.
Smart Images
Figure CN122398869A_ABST